These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34138988)

  • 21. Surgical outcomes of bridge-to-bridge therapy with extracorporeal left ventricular assist device for acute myocardial infarction in cardiogenic shock.
    Tokunaga C; Iguchi A; Nakajima H; Chubachi F; Hori Y; Takazawa A; Hayashi J; Asakura T; Yoshitake A
    BMC Cardiovasc Disord; 2022 Feb; 22(1):54. PubMed ID: 35172726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation.
    Salna M; Garan AR; Kirtane AJ; Karmpaliotis D; Green P; Takayama H; Sanchez J; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):499-506. PubMed ID: 31986207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant tricuspid valve repair in left ventricular assist device implantation may increase the risk for temporary right ventricular support but does not impact overall outcomes.
    Mihalj M; Jezovnik MK; Benk J; Heg D; Podstatzky-Lichtenstein T; Beyersdorf F; Radovancevic R; Gregoric ID; Hunziker L; Siepe M; Reineke D
    Eur J Cardiothorac Surg; 2022 Dec; 63(1):. PubMed ID: 36469336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of continuous flow left ventricular assist device after surgical left ventricular restoration.
    Gyoten T; Ono M
    Gen Thorac Cardiovasc Surg; 2023 Aug; 71(8):480-486. PubMed ID: 36810746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early and mid-term outcomes of left ventricular assist device implantation and future prospects.
    Hata H; Fujita T; Shimahara Y; Sato S; Yanase M; Seguchi O; Sato T; Nakatani T; Kobayashi J
    Gen Thorac Cardiovasc Surg; 2015 Oct; 63(10):557-64. PubMed ID: 25802124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure.
    Tang PC; Haft JW; Romano MA; Bitar A; Hasan R; Palardy M; Wu X; Aaronson KD; Pagani FD
    J Thorac Cardiovasc Surg; 2020 Mar; 159(3):897-905.e4. PubMed ID: 31101350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
    Mulloy DP; Bhamidipati CM; Stone ML; Ailawadi G; Kron IL; Kern JA
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):566-73; discussion 573-4. PubMed ID: 23246055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in utilization, mortality, and resource use after implantation of left ventricular assist devices in the United States.
    Sanaiha Y; Downey P; Lyons R; Nsair A; Shemin RJ; Benharash P
    J Thorac Cardiovasc Surg; 2021 Jun; 161(6):2083-2091.e4. PubMed ID: 32249087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Off-pump implantation of left ventricular assist device via minimally invasive left thoracotomy: Our single-center experience.
    Karahan M; Kervan Ü; Kocabeyoğlu SS; Sert DE; Akdi M; Yılmaz A; Koçak C; Çatav Z
    Turk Gogus Kalp Damar Cerrahisi Derg; 2023 Jan; 31(1):37-44. PubMed ID: 36926145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
    Russell SD; Rogers JG; Milano CA; Dyke DB; Pagani FD; Aranda JM; Klodell CT; Boyle AJ; John R; Chen L; Massey HT; Farrar DJ; Conte JV;
    Circulation; 2009 Dec; 120(23):2352-7. PubMed ID: 19933938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device.
    Han J; Takeda K; Takayama H; Kurlansky PA; Mauro CM; Colombo PC; Yuzefpolskaya M; Fukuhara S; Truby LK; Topkara VK; Garan AR; Mancini DM; Naka Y
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):520-7.e1. PubMed ID: 26806510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiology of the native heart and Thermo Cardiosystems left ventricular assist device complex at rest and during exercise: implications for chronic support.
    Branch KR; Dembitsky WP; Peterson KL; Adamson R; Gordon JB; Smith SC; Jaski BE
    J Heart Lung Transplant; 1994; 13(4):641-50; discussion 651. PubMed ID: 7947881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporary Right Ventricular Assist Device Insertion via Left Thoracotomy after Left Ventricular Assist Device Implantation.
    Park I; Cho YH; Chung SR; Jeong DS; Sung K; Kim WS; Lee YT
    Korean J Thorac Cardiovasc Surg; 2019 Apr; 52(2):105-108. PubMed ID: 31089448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
    Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunocompetent cells in durable ventricular assist device-implanted non-ischaemic dilated cardiomyopathy.
    Koga-Ikuta A; Fukushima S; Ishibashi-Ueda H; Tadokoro N; Kakuta T; Watanabe T; Fukushima N; Suzuki K; Fukui T; Fujita T
    Gen Thorac Cardiovasc Surg; 2022 Aug; 70(8):685-693. PubMed ID: 35229229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of right ventricular assist device implantation following left ventricular assist device implantation: Systematic review and meta-analysis.
    Reid G; Mork C; Gahl B; Appenzeller-Herzog C; von Segesser LK; Eckstein F; Berdajs DA
    Perfusion; 2022 Nov; 37(8):773-784. PubMed ID: 34112048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review of New-Onset Ventricular Arrhythmia after Left Ventricular Assist Device Implantation.
    Shi J; Yu X; Liu Z
    Cardiology; 2022; 147(3):315-327. PubMed ID: 35483328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MitraClip procedure prior to left ventricular assist device implantation.
    Dogan G; Hanke JS; Ricklefs M; Chatterjee A; Feldmann C; Mashaqi B; Deniz E; Haverich A; Schmitto JD
    J Thorac Dis; 2018 Jun; 10(Suppl 15):S1763-S1768. PubMed ID: 30034850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices.
    Maltais S; Topilsky Y; Tchantchaleishvili V; McKellar SH; Durham LA; Joyce LD; Daly RC; Park SJ
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1370-6. PubMed ID: 21839483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.